Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Ginestier

Showing results (41-50 of 98) with videos related to

Pageof 10
Sort By:
Cancer Research|April 19, 2011
Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survivalInes A Silva, Shoumei Bai, Karen McLean, et al.
Stem Cell Reports|October 23, 2018
The SCRIB Paralog LANO/LRRC1 Regulates Breast Cancer Stem Cell Fate through WNT/β-Catenin SignalingLeonor Lopez Almeida, Michael Sebbagh, François Bertucci, et al.
Oncogene|April 5, 2005
Junctional recruitment of mammalian Scribble relies on E-cadherin engagementChristel Navarro, Sébastien Nola, Stéphane Audebert, et al.
Breast Cancer Research : BCR|June 3, 2014
Aldehyde dehydrogenase and estrogen receptor define a hierarchy of cellular differentiation in the normal human mammary epitheliumGabriella Honeth, Sara Lombardi, Christophe Ginestier, et al.
Stem Cells (Dayton, Ohio)|May 19, 2012
Mevalonate metabolism regulates Basal breast cancer stem cells and is a potential therapeutic targetChristophe Ginestier, Florence Monville, Julien Wicinski, et al.
Theranostics|August 7, 2025
The LRP4/YAP axis drives the radiation-tolerant persister (RTP) cell state in breast cancerViolaine Forissier, Julien Wicinski, Martin Castagné, et al.
Communications Biology|August 7, 2023
Experimental and spontaneous metastasis assays can result in divergence in clonal architectureAntonin Serrano, Tom Weber, Jean Berthelet, et al.
Journal of Clinical Medicine|May 9, 2019
Stem Cells Inhibition by Bevacizumab in Combination with Neoadjuvant Chemotherapy for Breast CancerRenaud Sabatier, Emmanuelle Charafe-Jauffret, Jean-Yves Pierga, et al.
Cancer Research|February 12, 2005
Protein expression profiling identifies subclasses of breast cancer and predicts prognosisJocelyne Jacquemier, Christophe Ginestier, Jacques Rougemont, et al.
The Journal of Clinical Investigation|January 7, 2010
CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenograftsChristophe Ginestier, Suling Liu, Mark E Diebel, et al.
Pageof 10

Showing results (41-50 of 98) with videos related to

Sort By:
Pageof 10
Cancer Research|April 19, 2011
Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survivalInes A Silva, Shoumei Bai, Karen McLean, et al.
Stem Cell Reports|October 23, 2018
The SCRIB Paralog LANO/LRRC1 Regulates Breast Cancer Stem Cell Fate through WNT/β-Catenin SignalingLeonor Lopez Almeida, Michael Sebbagh, François Bertucci, et al.
Oncogene|April 5, 2005
Junctional recruitment of mammalian Scribble relies on E-cadherin engagementChristel Navarro, Sébastien Nola, Stéphane Audebert, et al.
Breast Cancer Research : BCR|June 3, 2014
Aldehyde dehydrogenase and estrogen receptor define a hierarchy of cellular differentiation in the normal human mammary epitheliumGabriella Honeth, Sara Lombardi, Christophe Ginestier, et al.
Stem Cells (Dayton, Ohio)|May 19, 2012
Mevalonate metabolism regulates Basal breast cancer stem cells and is a potential therapeutic targetChristophe Ginestier, Florence Monville, Julien Wicinski, et al.
Theranostics|August 7, 2025
The LRP4/YAP axis drives the radiation-tolerant persister (RTP) cell state in breast cancerViolaine Forissier, Julien Wicinski, Martin Castagné, et al.
Communications Biology|August 7, 2023
Experimental and spontaneous metastasis assays can result in divergence in clonal architectureAntonin Serrano, Tom Weber, Jean Berthelet, et al.
Journal of Clinical Medicine|May 9, 2019
Stem Cells Inhibition by Bevacizumab in Combination with Neoadjuvant Chemotherapy for Breast CancerRenaud Sabatier, Emmanuelle Charafe-Jauffret, Jean-Yves Pierga, et al.
Cancer Research|February 12, 2005
Protein expression profiling identifies subclasses of breast cancer and predicts prognosisJocelyne Jacquemier, Christophe Ginestier, Jacques Rougemont, et al.
The Journal of Clinical Investigation|January 7, 2010
CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenograftsChristophe Ginestier, Suling Liu, Mark E Diebel, et al.
Pageof 10